Philip Oyer
Publication Details
-
Heart transplant graft survival is improved after a reduction in panel reactive antibody activity.
J Thorac Cardiovasc Surg. 2013; (2): 555-64; discussion 564-5
Allosensitization in potential orthotopic heart transplant recipients is evaluated with the panel reactive antibody assay. Sensitized patients have prolonged wait times and increased waitlist and post-transplant mortality. Although low panel reactive antibody activity at the time of orthotopic heart transplantation is associated with improved outcomes, literature regarding the survival benefit of a panel reactive antibody reduction in the sensitized orthotopic heart transplant recipient remains limited.
Help